Total Laryngectomy
3
Pipeline Programs
1
Companies
4
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
1
1
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
Atos MedicalSweden - Horby
4 programs1
1
1
Provox Vega voice prosthesis 22.5 FrPhase 21 trial
Provox voice prosthesisPhase 1/21 trial
Provox Xtra HMEPhase 11 trial
Provox Vega voice prosthesisN/A1 trial
Active Trials
+1 more trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Atos MedicalProvox Vega voice prosthesis 22.5 Fr
Atos MedicalProvox voice prosthesis
Atos MedicalProvox Xtra HME
Atos MedicalProvox Vega voice prosthesis
Clinical Trials (4)
Long Term Use of the Provox Vega 22.5
Start: Feb 2008Est. completion: Mar 2010
Phase 2Completed
Short-term Clinical Feasibility of the New Provox Vega 22.5 Voice Prosthesis
Start: Apr 2008Est. completion: Apr 2009
Phase 1/2Completed
Short-term Clinical Feasibility of the Provox XtraHMEs for Pulmonary Rehabilitation After Total Laryngectomy
Start: Jul 2009Est. completion: Aug 2009
Phase 1Completed
Long-term Clinical Feasibility of the New Indwelling Provox Vega 20 Voice Prosthesis
Start: Mar 2008Est. completion: Mar 2009
N/ATerminated
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 companies competing in this space